Page 155 - Read Online
P. 155

de Moura et al. Mini-invasive Surg 2017;1:148-52                   Mini-invasive Surgery
           DOI: 10.20517/2574-1225.2017.27
                                                                                                www.misjournal.net
            Topic: Achalasia Management: the South American viewpoint                           Open Access


           Endoscopic pneumatic dilatation and

           peroral endoscopic myotomy in dilated

           megaesophagus




           Eduardo Turiani Hourneaux de Moura, Eduardo Guimarães Hourneaux de Moura
           Gastrointestinal Endoscopy Unit, Hospital das Clinicas, University of São Paulo Medical School, São Paulo, SP 01246-903, Brazil.

           Correspondence to: Dr. Eduardo Turiani Hourneaux de Moura, Gastrointestinal Endoscopy Unit, Hospital das Clinicas, University of São Paulo Medical
           School, 255, São Paulo, SP 01246-903, Brazil. E-mail: duduthmoura@gmail.com

           How to cite this article: de Moura ETH, de Moura EGH. Endoscopic pneumatic dilatation and peroral endoscopic myotomy in dilated megaesophagus.
           Mini-invasive Surg 2017;1:148-52.

                                         ABSTRACT
            Article history:              Achalasia is a primary esophageal disorderth variable causes, with an incidence between 0.03
            Received: 20 Jul 2017         to 1/100,000 people, and prevalence of approximately 10/100,000, with no difference between
            First Decision: 1 Aug 2017    gender. It is more frequent in South and Central America, where Chagas disease is endemic.
            Revised: 11 Sep 2017          There are several methods to treat achalasia including endoscopic and surgical procedures,
            Accepted: 28 Sep 2017         however, all of these methods are palliative.  This article discusses 2 different endoscopic
            Published: 28 Dec 2017        methods to treat advanced megaesophagus in Chagas disease, pneumatic balloon dilatation
                                          (PBD), and peroral endoscopic myotomy (POEM). Although varying between studies, PBD has
            Key words:                    an average symptom relief in 93% of patients in 6 months and 44% in 6 years. Some risk factors
            Chagas disease,               for failure of PBD are: younger age, male gender, a wider esophagus, poor emptying on post-
            megaesophagus,                treatment barium esophagogram and Eckardt scale < 3 before the treatment. Despite relatively
            sigmoid-shaped esophagus,     short-term follow-up of an average of 3 years, POEM has excellent results. The clinical success
            pneumatic dilatation,         achieved in 98 % with the Eckardt score decreased from 6.9 preoperatively to 0.77. Regarding
            peroral endoscopic myotomy,   sigmoid-shaped esophagus, only a few papers have been published on POEM. The largest
            endoscopic gastrointestinal   population was 32 patients with a follow-up of 2 years. There was an efficacy of 96%, with the
            surgery procedures            Eckardt scale decreasing from 7.8 to 1.4. In conclusion, PBD, is still widely used mainly due to
                                          its availability, especially in patients with a higher surgical risk and in patients who already had
                                          a Heller myotomy who persist or develop dysphagia. POEM has already demonstrated excellent
                                          results, but it requires advanced technical skills and Long-term results and randomized clinical
                                          trials are needed to validate the use of POEM in routine clinical practice.


           INTRODUCTION                                       It is more frequent in South and Central America, where
                                                              Chagas  disease  is  endemic.  In  addition  to  infectious
           Achalasia is a primary esophageal disorder of variable   etiology,  other  causes  of  achalasia  are  idiopathic,
           causes, with an incidence between 0.03 to 1/100,000   autoimmune, or drug-related .
                                                                                       [5]
           people, and a prevalence of approximately 10/100,000,
           with no difference between gender [1-4] .          Chagas disease is an incurable disease where there

                                                                                              Quick Response Code:
                       This is an open access article licensed under the terms of Creative Commons Attribution 4.0 International
                       License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution,
            and reproduction in any medium, as long as the original author is credited and the new creations are licensed under the
            identical terms.
            For reprints contact: service@oaepublish.com

            148  © The Author(s) 2017                                                                                                                                            www.oaepublish.com
   150   151   152   153   154   155   156   157   158   159   160